Yann Godet
Besancon, 25000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Metformin dual-targets metabolism and survival pathways in BPDCN.
Journal: iScience
Published: July 30, 2025
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.
Journal: Molecular therapy. Methods & clinical development
Published: February 07, 2025
Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.
Journal: Cancer immunology, immunotherapy : CII
Published: September 30, 2024
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.
Journal: Cell reports. Medicine
Published: September 23, 2024
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.
Journal: Cancer immunology research
Published: February 28, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy.
Journal: Cancer gene therapy
Published: February 07, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.
Journal: Cancer immunology research
Published: July 10, 2023
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
Journal: Cancers
Published: May 20, 2022
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy.
Journal: Cancers
Published: November 29, 2021
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells.
Journal: Cancer gene therapy
Published: May 10, 2021
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Journal: The Journal of investigative dermatology
Published: November 18, 2020
Last Updated: 09/26/2026